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Abstract 
Purpose: To evaluate α-glucosidase and α-chymotrypsin enzyme inhibitory activity of Jatropha 
gossypifolia as a probable remedy for the management of diabetes and ulcer. 
Methods: Different extracts and fractions of the root, leaf and stem bark of the plant were screened for 
their α-glucosidase and α-chymotrypsin inhibitory activity using standard in vitro inhibition assays. 
Acarbose and chymostatin were used as positive control, respectively. 
Results: n-Butanol and ethyl acetate fraction showed maximum enzyme inhibition for α-glucosidase 
with 67.93 ± 0.66 and 67.67 ± 0.71 % and half maximal concentration (IC50) of 218.47 ± 0.23 and 
213.45 ± 0.12 µg/ml, respectively. Dichloromethane and ethyl acetate leaf fractions exhibited maximum 
α-chymotrypsin inhibition activity of 85.08 ± 0.38 and 83.87 ± 0.70 %, and IC50 of 133.1 ± 0.68 and 
134.5 ± 0.12 µg/ml, respectively, Acarbose exhibited enzyme inhibition activity of 92.14 ± 0.38 % with 
IC50 of 38.24 ± 0.1 µg/ml, while chymostatin exhibited 93.67 ± 0.38 % enzyme inhibition and IC50 of 8.24 
± 0.11 µg/ml. 
Conclusion: The presence of bioactive secondary metabolities with enzyme-inhibiting activity lends 
some support for the traditional use of this plant in the management of diabetes and ulcer. However, 
further investigation of the plant including identification of its active components is required. 
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Plants have always played a major role in the 
treatment of human and animal diseases as a 
therapeutic source for traditional medicine [1]. 
Enzymes are usually made up of proteins that 
are helpful in catalyzing chemical reactions. 
Enzymes increase the rate of reactions until they 
acquire the equilibrium, although they do not 
alter thermodynamic properties of the reaction 
[2].  
 
Diabetes mellitus is a chronic disorder of 
metabolism caused by an absolute or relative 
lack of insulin. It is characterized by 
hyperglycemia in postprandial and fasting state, 
and its severe form is accompanied by ketosis 
and protein wasting [3].  Elevated postprandial 
hyperglycemia (PPHG) is one of the risk factors 
[4]. PPHG is elevated by the action of α-
glucosidase and α-amylase. Inhibition of these 
enzymes plays a major role in managing PPHG 
in diabetic patients. Inhibition of α-glucosidase 
enzyme activity leads to a reduction in 
disaccharide hydrolysis which has beneficial 
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effects on glycemic index control in diabetic 
patients [5,6].  
 
Several α-glucosidase inhibitors have been 
isolated from medicinal plants for the 
development of new drugs with increased 
potency and lower adverse effects than the 
existing drugs [7]. α-Chymotrypsin is a serine 
protease enzyme, which acts to alleviate ulcers 
and digesting the polypeptide of damaged tissue 
[8]. Recently, serine protease inhibitors from 
potato and other plants have also been reported 
to have inhibitory effects on tumor cell growth 
[9,10]. Such inhibitors have potential therapeutic 
use. Herbal medicines become important factors 
in the treatment of gastro-duodenal diseases, as 
they prove themselves to be free of side effects 
and are less expensive than synthetic drugs. 
Clinical research has confirmed the efficiency of 
several plants for the treatment of 
gastroduodenal diseases [11,12]. The medicinal 
properties of many plants are mainly assigned to 
the flavonoids present, but they may be 
influenced also by other compounds such as 
coumarins, alkaloids, terpenoids, tannins, 
phenolic acids and antioxidant micronutrients 
such as Cu, Mn and Zn1 [13,14]. 
 
Jatropha gossypifolia belongs to the family, 
“Euphorbiaceae” and the order, “Geraniale”. The 
common name of J. gossypifolia is bellyache 
bush, pignut or fignut. In Yourba land it is known 
as “Lapalapa” [15]. Jatropha gossypifolia is an 
erect, monoecious, deciduous, soft wooded and 
perennial shrub which grows with the average 
height of 2.5 m but exceeding 4 m in some 
areas. Its leaves are sticky which are covered 
with extra-floral nectaries, deeply 3-lobed and 
bronze when juvenile but green when mature. 
Flowers are deep red in color with yellow 
centres. Fruits are triocular, explosively 
dehiscent capsules having a single seed per 
locule. Capsules are green in color at maturity 
which turn pale green before dehiscence and are 
sparsely hairy. Seeds are spherical, carunculate 
and greyish-brown with copious starchy 
endosperm [16]. It is a bushy gregarious shrub 
which grows mostly throughout India. Its bark 
contains the alkaloids named jatrophine and a 
lignin named jatrodien found in the stems [17].  
 
Ethnobotanical uses of J. gossypifolia have been 
reported for cancer, diarrhea, dysentery, skin 
diseases (leprosy), arthritis, ulcer, gum infections 
and wound healing [18,19]. This study was 
aimed at investigating the occurrence of 
constituents in Jatropha gossypifolia plant 
extracts with enzyme inhibition activity against α-




Chemicals and drugs 
 
Enzymes including α-Glucosidase (CAS 9000-
81-1 Sigma-Aldrich GmbH USA),  and α-
Chymotrypsin (CAS 9001-08-5 Sigma- Aldrich 
GmbH USA), substrates p-nitrophenyl 
glucopyranoside (CAS1866-15-5 Sigma-Aldrich 
UK), N-succinyl phenyl-alanine-P-nitroanilide), 
DTNB 5,5-dithio-bis-nitrobenzoic acid (CAS 69- 
78-3 Sigma-Aldrich Germany), Acarbose and 
Chymosatin Sp. (CAS 1933-04-4 Sigma-Aldrich 
France) were used for enzyme inhibition study. 
For preparation of buffer, di-potassium hydrogen 
phosphate (K2HPO4), potassium di-hydrogen 
phosphate (KH2PO4), potassium hydroxide used 
were of extra pure analytical grade. All the 
chemicals used in the extraction process were 
obtained from Merck Group Frankfurter Strabe 




J. gossypifolia was collected from the 
surroundings of the district of Bhawalpur, Punjab, 
Pakistan. The plant was identified by Dr 
Muhammad Arshad (late) of Cholistan Institute of 
Desert Studies (CIDS) in The Islamia University 
of Bahawalpur (IUB) and a voucher specimen 
(no. 3210/CIDS/IUB) was deposited in the CIDS, 





Firstly whole plant specimens were collected and 
the leaves, stem/bark and root portion of the 
plants were separated. The stem/bark and the 
root portions were subjected to shade drying 
whereas the leaves were first ground and the 
frozen at -20 oC for three days following which 
they were freeze dried using lyophilizer. 
 
The dried plant material was ground to fine 
powder. The powdered root portion (1 kg) was 
initially extracted with dichloromethane (DCM) 
successively for 72 h and then with methyl 
alcohol (MA) again for 72 h at room temperature 
with periodic agitation. The stem/bark powder (1 
kg) was also extracted with MA for 7 days with 
periodic agitation. 
 
The leaves powder (1 kg) was extracted with MA 
for 7 days with periodic agitation. All of these 
extracts were filtered and then concentrated 
under reduced pressure using a rotary 
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evaporator at 37 oC and was finally obtained as 
semisolid these extracts were weighed and 
stored in a refrigerator in air tight vials. 
 
The concentrated methyl alcohol (MA) crude 
extracts of the leaves portion was further 
subjected to fractionation with n-hexane (nH), 
MC, ethyl acetate (EA) and n-butanol (nB) [thrice 
with each solvent] respectively. The filtrates of 
the respective fractions thus obtained were 
concentrated under reduced pressure by rotary 
evaporator at 37 oC. The respective concentrates 
were weighed and stored in labeled airtight vial in 
a refrigerator and named as JGRD (Jatropha 
gossypifolia roots dichloromethane extract), 
JGRM (Jatropha gossypifolia root methanol 
extract), JGLCr (Jatropha gossypifolia leaves 
crude extract), JGLH (Jatropha gossypifolia 
leaves hexane extract), JGLD (Jatropha 





The α-glucosidase inhibition activity was 
performed according to the standard method with 
slightly modification [20]. Total volume of the 
reaction mixture of 100 µl contained 70 µl 50 mM 
phosphate buffer saline, pH 6.8, 10 µl (0.5 mM) 
test compound, followed by the addition of 10 µl 
(0.057 units) enzyme. The contents were mixed, 
preincubated for 10 min at 37 ºC and pre-read at 
400 nm. The reaction was initiated by the 
addition of 10 µl of 0.5 mM substrate (p-
nitrophenyl glucopyranoside). Acarbose was 
used as positive control. After 30 min of 
incubation at 37 ºC, absorbance was measured 
at 400 nm using Synergy HT microplate reader. 
All experiments were carried out in duplicates. 
Inhibition was calculated as in Eq 1. 
 
Inhibition (%) = {(Control – Test)/Control} 100 …… (1) 
 
where control = total enzyme activity without 
inhibitor, and test = activity in the presence of 
test compound. 
 
IC50 values (concentration at which there is 50 % 
enzyme catalyzed reaction) were calculated 
using EZ-Fit Enzyme Kinetics Software (Perrella 




Chymotrypsin inhibition activity was performed 
according to slightly modified method of Rehman 
et al. A total volume of 100 μl assay mixture 
contained 60 μl Tris-HCl buffer (50 mM pH 7.6), 
10 μl test compound and 15 μl (0.9 units) purified 
chymotrypsin enzyme (Sigma, USA). The 
contents were mixed and incubated for 20 min at 
37 oC and pre-read at 410 nm. The reaction was 
initiated by the addition of 15 μl (1.3 mM) 
substrate (N-succinyl phenyl-alanine-P-
nitroanilide). The change in absorbance was 
observed after 30 min at 410 nm. Synergy HT 
(BioTek, USA) 96-well plate reader was used in 
all experiment. All reactions were performed in 
triplicates. The positive and negative controls 
were included in the assay. Chymostatin (0.5 mM 
well) was used as a positive control. Percentage 




Mean ± SEM of the data were calculated and the 
extract concentration providing 50 % inhibition 
(IC50) was calculated from the plot of percent 
inhibition versus extract concentrations in 
solution, using Microsoft Excel program. P < 0.05 
was considered statistically significant. Graph 





Different extracts and fractions of roots, 
stem/bark and leaves of Jatropha gossypifolia 
were tested against the α-glucosidase and α-
chymotrypsin enzyme inhibitory activity (Table 1) 
and IC50 values were also calculated (Table 2). 
 
n-Butanol and ethyl acetate fractions showed 
maximum % enzyme inhibition for α-glucosidase 
with 67.93 ± 0.66 and 67.67 ± 0.71 and IC50 of 
218.47 ± 0.23 and 213.45 ± 0.12 % enzyme 
inhibition, respectively. While maximum a-
chymotrypsin % inhibition activity was observed 
with DCM leaves 85.08 ± 0.38, ethyl acetate 
leaves 83.87 ± 0.71, DCM roots 81.45 ± 0.69, 
root methanol 75.00 ± 0.99, crude leaves 
methanol 71.77 ± 0.57 with IC50 values of 133.1 
± 0.68,  34.5 ± 0.12,  129.5 ± 0.17, 118.3 ± 0.29, 




The use of medicinal plants is mainly based on 
local tradition and not on scientific knowledge 
[21]. The chemical constituents of most of these 
plants are unknown and may have dangerous 
effects on human health. On the other hand, 
some plants, which are not reported to be used 
in herbal medicine, might also possess potential 
activity. In traditional practices, numerous plants 
have been used to treat cognitive disorders, 
including neurodegenerative diseases and 
different neuropharmacological disorders.  
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Table 1: α-Glucosidase and α-chymotrypsin inhibitiory activity (mean ± SEM, n = 3) of different extracts of 
Jatropha gossypifolia 
 
Sample code Glucosidase inhibition (%) Chymotrypsin inhibition (%) 
JGRD 42.57±0.69 81.45±0.69 
JGRM 52.26±0.99 75.00±0.99 
JGLCr 51.99±0.57 71.77±0.57 
JGLH 46.47±0.23 42.47±0.23 
JGLD 55.62±0.38 85.08±0.38 
JGLE 67.67±0.71 83.87±0.71 
JGLB 67.93±0.66 44.49±0.66 
JGACr 43.52±0.77 64.52±0.77 
Control 92.14±0.38 93.67±0.38 
*Control = Acarbose for glucosidase and chymostatin for chymotrypsin; *JGRD = Jatropha gossypifolia roots 
dichloromethane extract; *JGRM = Jatropha gossypifolia root methanol extract); *JGLCr = Jatropha gossypifolia 
leaves crude extract; *JGLH = Jatropha gossypifolia leaves n-hexane extract; *JGLD = Jatropha gossypifolia 
leaves dichloromethane extract; *JGLE = Jatropha gossypifolia leaves ethyl acetate extract; *JGLB = Jatropha 
gossypifolia leaves n-butanol extract 
 
Table 2: IC50 values of α-glucosidase and α-Chymotrypsin (mean ± SEM, n=3) of different extracts of Jatropha 
gossypifolia 
 
Sample code Glucosidase IC50(µg/ml) Chymotrypsin IC50(µg/ml) 
JGRD NIL 129.5±0.17 
JGRM <400 118.3±0.29 
JGLCr <400 121.7±0.19 
JGLH NIL NIL 
JGLD 392.41±0.68 133.1±0.68 
JGLE 213.45±0.12 134.5±0.12 
JGLB 218.47±0.23 NIL 
JGACr NIL 116.9±0.16 
Control 38.24±0.11(µM) 8.24±0.11 
*Control = acarbose for glucosidase, and chymostatin for chymotrypsin 
 
The history of drug discovery has shown that 
plants contain active compounds that have 
become new sources to investigate for the 
pharmaceutical industry [22]. 
 
The extracts from Jatropha gossypifolia plants 
showed significant α-glucosidase activity. α-
glucosidases comprises a family of enzymes 
hydrolase, located in the brush-border surface 
membrane of small intestinal cells and it is the 
key enzyme by which the final step of digestion is 
catalyzed, so glucosidase inhibitors can stop the 
liberation of D-glucose from complex dietary 
carbohydrates and can delay the glucose 
absorption which in turn reduce plasma glucose 
level and decrease hyperglycemia [23]. Several 
synthetic glucosidase inhibitors such as 
acarbose, miglitol, voglibose are used as 
treatment for diabetes but their prices are high 
and side effects occur [24]. Due to these issues, 
there has been a search for some other safe and 
effective glucosidase inhibitors of natural origin in 
order to develop a physiological functional food 
and lead compound for diabetic treatment 
[25,26]. 
 
The chymotrypsin enzyme inhibitory activity was 
performed by using chymostatin as a standard. 
The relative percent enzyme inhibition along with 
IC50 of all the extracts and standard were 
analyzed. Epidemiological studies demonstrating 
a decrease in occurrence of breast, colon and 
prostatic cancers in vegetarian populations has 
suggested the role of plant proteinase inhibitors 
in preventing these cancers. A soybean-derived 
Bowman-Birk protease inhibitor (BBI) either 
inhibits or prevents development of 
experimentally induced colon, oral, lung, liver 
and esophageal cancers. This anti carcinogenic 
effect of the Bowman-Birk protease inhibitor is 
thought to stem from its ability to inhibit 




In the light of these findings, we can conclude 
that the plant extracts screened herein showed 
inhibitory activity against both of the enzymes 
and they could be considered for further studies 
in the treatment of diabetes and ulcer as natural 
remedy. Further works related to the isolation of 
Saleem et al 
Trop J Pharm Res, January 2016; 15(1): 125  
 
the active constituents through bioassay-directed 
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